Gowlings Logo Life Sciences News @ Gowlings
April 13, 2012

Life Sciences News @ Gowlings image
  Use Twitter?    Follow Gowlings news on Twitter

Illumina share price drops as Roche's takeover attempts hit a wall http://www.pharmatimes.com/Article/12-04-13/Illumina_share_price_drops_as_Roche_s_takeover_attempts_hit_a_wall.aspx

Roche jeers at Illumina's boasts as proxy fight escalates http://www.fiercepharma.com/story/roche-jeers-illuminas-boasts-proxy-fight-escalates/2012-04-12

Shire buys into regenerative medicine with Pervasis purchase http://www.pharmatimes.com/Article/12-04-13/Shire_buys_into_regenerative_medicine_with_Pervasis_purchase.aspx

Humira takes top spot in drug sales http://www.fiercepharma.com/story/humira-takes-top-spot-drug-sales/2012-04-11



Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2012 Gowling Lafleur Henderson LLP. All rights reserved.